biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Amazingly….

<< Previous

Bullboard Posts

Next >>

Comment by lovingoldon Feb 20, 2022 12:25pm

80 Views

Post# 34446304

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Amazingly….

You and other longs stlll can't answer me. Again, you continue to prove my point.

I think you are having a difficult time discerning the difference between can't and won't.
It's not that we can't answer you, it's that we won't answer you.

See my last post ... why should we? you won't believe a word of it anyways ;)

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia